See What’s Happening
News and Events
June 21, 2019: Anapneo Therapeutics Wins University of Chicago Innovation Fund Competition
The Polsky Center for Innovation and Entrepreneurship at the University of Chicago announced today that it plans to make a $250,000 SAFE (Simple Agreement for Future Equity) investment in Anapneo Therapeutics. This investment is being made as a result of Anapneo’s victory in the Spring, 2019 George Schultz Innovation Fund competition.
June 5, 2019: Anapneo Therapeutics Presents at University of Chicago George Schultz Innovation Fund Competition
Anapneo Therapeutics was one of four finalists presenting today at a research symposium sponsored by the University of Chicago George Schultz Innovation Fund. The symposium audience of approximately 180 included members of the Innovation Fund advisory committee; University of Chicago students, faculty, and alumni; and members of Chicago’s entrepreneurial and investing community.
April 23, 2019: Anapneo Therapeutics Presents at Science2Startup
Anapneo Therapeutics presented their novel technology to treat sleep apnea to nearly 200 biotechnology industry scientists, executives, and investors today at the Science2Startup symposium in Cambridge, MA. Anapneo was one of 12 organizations selected from more than 170 applicants to present at this symposium. An abbreviated copy of the Anapneo slide deck from this presentation can be accessed here .
March 18, 2019: Anapneo Therapeutics Selected as a Finalist in University of Chicago Innovation Fund Competition
Anapneo Therapeutics has been selected as one of four finalists in the Spring, 2019 George Schultz Innovation Fund competition sponsored by the Polsky Center for Entrepreneurship and Innovation at the University of Chicago. Following an extensive due diligence process led by Innovation Fund Associates, Anapneo will present their novel technology for therapy of sleep apnea to the Innovation Fund advisory committee at a symposium to be held in June, 2019.
January 24, 2019: Anapneo Therapeutics Selected to Present at Science2Startup
Anapneo Therapeutics has been selected to present its novel technology to treat sleep disordered breathing (sleep apnea) at the 2019 Science2Startup meeting in Cambridge, MA, in April, 2019. Science2Startup is an invitation-only symposium that features the most innovative therapeutics startup ideas from the world’s top research institutions, and provides a forum for university-based researchers to present their ideas and interact with leading investors and executives.
University of Chicago
IIT Research Institute